qxnews

To view this email as a web page, click here

This week's sponsor is Premier Research.
	Heartbreak No Longer: Winning the Battle Against Psoriasis New treatments have broken the cycle of despair for people with severe psoriasis. Learn about the latest advances — and what to expect next — at our March 29 webinar. Register today. Premier Research. It's what we do. Best.

Today's Rundown

Featured Story

Novo Nordisk said to be in the hunt for Global Blood Therapeutics

Thursday, March 9, 2017

With pricing pressure mounting in the diabetes space, insulin specialist Novo Nordisk may be looking to wean itself off its core focus with a rumored buyout for Global Blood Therapeutics, a buy that could help boost its own blood disorder business.

This week's sponsor is Veeva.
	Survey \| The Veeva 2017 Unified Clinical Operations Survey Share your thoughts on the life sciences industry’s progress in reducing system and process complexity to improve study execution. he first 50 qualified respondents will receive a $10 Amazon gift card, as well as a $10 donation made to Doctors Without Borders in their name. Complete the Survey Now!

Bristol-Myers replaces CSO at key point for pipeline

Thursday, March 9, 2017

Bristol-Myers Squibb has appointed Thomas Lynch to replace Francis Cuss as CSO. The reshuffle puts the former CEO of Massachusetts General Physicians Organization in charge of returning the lustre to Bristol-Myers’ R&D pipeline after a period in which setbacks to Opdivo have dampened expectations.

Cancer specialist BeyondSpring lands on the Nasdaq with a $54M IPO

Thursday, March 9, 2017

Cancer therapeutics biotech BeyondSpring scored $54.3 million in a combination IPO and private placement. The total falls well short of its initial $100 million target and relied almost exclusively on the placement for the bulk of its cut-price raise.

Parkinson’s nonprofit founds virtual single-asset biotech

Thursday, March 9, 2017

Nonprofit Parkinson’s UK has teamed up with the University of Sheffield to create a virtual biotech. The single-asset startup will work with service providers to advance an Nrf2 inhibitor toward the clinic.

Spero plans to have two antibiotics for resistant pathogens in pivotal trials next year

Thursday, March 9, 2017

Buoyed by a third-round fundraising that netted $51.7 million, antibiotic developer Spero Therapeutics says it will be able to accelerate clinical development of two drugs against drug-resistant infections recently highlighted by the WHO.

Report: CROs should consider Asian countries as trial sites for these reasons

Wednesday, March 8, 2017

Patient recruitment has been named as a key factor for clinical trial failures and delays, and many CROs are turning their studies to vast populated Asian countries, boosting the region’s trial industry, a recent Frost & Sullivan report finds.

Merck KGaA in advanced talks to sell off biosims unit—and others could follow

Thursday, March 9, 2017

The rumors are true: When it comes to biosimilars, Merck KGaA has had enough. The German drugmaker is in advanced negotiations to sell its unit of biologic copycats, it said in its 2016 annual report.

This week's sponsors are Medpace and Diversigen.
	[Webinar] Opportunities and Challenges in Microbiome-based Clinical Research Thursday, April 6 \|11:30pm ET / 8:30am PT Join experts from Medpace and Diversigen in a discussion about the possibilities as well as the challenges in clinical research and development involving the human microbiome. Register Now!

News of Note

The FDA cleared Servier and Pfizer for U.S. trials of their CALM study for UCART19 in blood cancer, following the U.K. trial that started last year. Release

On the day BMS lost its CSO, Epizyme has also said its head of research and chief scientific officer, Robert Copeland, has retired from the biotech. Statement

The FDA has handed out its orphan drug designation tag for Boehringer's experimental anti-CD33 mAb in myelodysplastic syndromes. Release

Resources

[Survey] Veeva 2017 Unified Clinical Operations Survey

Presented By: Veeva

Share your thoughts on the life sciences industry’s progress in reducing system and process complexity to improve study execution. The first 50 qualified respondents will receive a $10 Amazon gift card, as well as a $10 donation made to Doctors Without Borders in their name. Finish the survey today!

Events

Drug Development Boot Camp® 2017

November 15-16, 2017 | Boston, MA

MIXiii-BIOMED 2017

May 23-25, 2017 | Tel Aviv, Israel

Today's Rundown

Featured Story

Novo Nordisk said to be in the hunt for Global Blood Therapeutics

Top Stories

Bristol-Myers replaces CSO at key point for pipeline

Cancer specialist BeyondSpring lands on the Nasdaq with a $54M IPO

Parkinson’s nonprofit founds virtual single-asset biotech

Spero plans to have two antibiotics for resistant pathogens in pivotal trials next year

Report: CROs should consider Asian countries as trial sites for these reasons

Merck KGaA in advanced talks to sell off biosims unit—and others could follow

News of Note

Resources

[Survey] Veeva 2017 Unified Clinical Operations Survey

[Whitepaper] Expert Advice: Designing Systems for Global Content Processes

[Whitepaper] Delayed and Confusing IDMP Requirements Demand Two-Part Strategy

[Whitepaper] Transformation Initiatives Underway for Regulatory Information Management

[Whitepaper] Considering an eTMF Solution? Industry Research Reveals the Top Benefits

[Whitepaper] The Trailblazer's Guide to Apps

Events